Baseline Clinical Features and Biomarker Profiles of the Childhood Arthritis and Rheumatology Research Alliance Systemic Juvenile Idiopathic Arthritis‐Associated Lung Disease Cohort

Documenti analoghi

• Transcriptional Profiling of Tofacitinib Treatment in Juvenile Idiopathic Arthritis: Implications for Treatment Response Prediction
  di: Esraa Eloseily, et al.
  Pubblicazione: (2024)
• Cumulative Social Disadvantage and Disease Activity in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study
  di: William Daniel Soulsby, et al.
  Pubblicazione: (2026)
• Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis
  di: Ekemini A. Ogbu, et al.
  Pubblicazione: (2024)
• Childhood Arthritis and Rheumatology Research Alliance Biologic Disease‐Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis
  di: Stacey E. Tarvin, et al.
  Pubblicazione: (2024)
• Incidence and Genetic Risk of Juvenile Idiopathic Arthritis in Norway by Latitude
  di: Sigrid V. Hestetun, et al.
  Pubblicazione: (2024)